Fairvalue-Calculator Fairvalue-Calculator
EN DE

Emova Group (ALEMV) Fair Value & Analysis

Consumer Cyclical · FR · Market cap €15.1M

Price€0.7850
Fair Value€1.76
Upside+124.2%
Quality95/100
Evidence: High Range €1.32 – €2.20

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Emova Group (ALEMV) currently trades at €0.7850, while our model-based Fair Value estimate is €1.76 — implying the stock looks roughly 124.2% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Emova Group SA engages in the retail sale of indoor plants in France. The company operates a network of own shops and entrepreneurial franchise stores under the Monceau Fleurs, Coeur de Fleurs, Happy, and Au Nom de la Rose brands. The company was formerly known as Groupe Monceau Fleurs S.A. and changed its name to Emova Group SA in April 2015. Emova Group SA was founded in 1965 and is headquartered in Issy-les-Moulineaux, France.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Emova Group (ALEMV) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €1.76 versus a price of €0.7850 — about +124% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ALEMV?
Our 21-model fair value for Emova Group is €1.76 (as of Jun 25, 2026), built from audited fundamentals. The current price is €0.7850.
What is the quality score of ALEMV?
Emova Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.